Funding for this research was provided by:
National Institutes of Health (U01CA195564)
Dr. Ralph and Marian Falk Medical Research Trust (FP059463-01)
University of Chicago Institute for Translational Medicine CTSA Pilot Grant Award
Ann Dudley Goldblatt Fellowship in Oncology (N/A)
Text and Data Mining valid from 2019-07-15
Received: 11 December 2018
Accepted: 24 June 2019
First Online: 15 July 2019
Ethics approval and consent to participate
: This study was approved by the University of Chicago IRB Committee (#IRB15–1401) on November 9th, 2015. Consent was waived as all patient information was de-identified and no prospective tissue samples were collected.
: Not applicable.
: K.D. received royalties from Hologic.M.L.G. is a stockholder in R2/Hologic, co-founder and equity holder in Quantitative Insights, and receives royalties from Hologic, GE Medical Systems, MEDIAN Technologies, Riverain Medical, Mitsubishi, and Toshiba.O.I.O. is co-founder of Cancer IQ and on the Scientific Advisory Board for Tempus.